G
Giuseppe Mancia
Researcher at University of Milano-Bicocca
Publications - 1465
Citations - 152794
Giuseppe Mancia is an academic researcher from University of Milano-Bicocca. The author has contributed to research in topics: Blood pressure & Ambulatory blood pressure. The author has an hindex of 145, co-authored 1369 publications receiving 139692 citations. Previous affiliations of Giuseppe Mancia include University of Milan & Instituto Politécnico Nacional.
Papers
More filters
Journal ArticleDOI
Modification of the baroreceptor control of atrio-ventricular conduction induced by digitalis in man
TL;DR: In man the baroreceptor control of atrio-ventricular conduction is strikingly potentiated by digitalis although this potentiation is only evident in the upper portion of the stimulus-response curve of the reflex.
Journal ArticleDOI
Erectile dysfunction and adherence to antihypertensive therapy: Focus on β-blockers.
TL;DR: Nebivolol presents a unique mode of action through enhanced nitric oxide bioavailability that may be associated with benefits on erectile function and represents the only exception in this class of drugs in terms of erectilefunction.
Journal ArticleDOI
Cardiovascular protection for all individuals at high risk: evidence-based best practice
George L. Bakris,Michael Böhm,Gilles R. Dagenais,Hans-Christoph Diener,Toshiro Fujita,Philip B. Gorelick,Sverre E. Kjeldsen,Markku Laakso,Giuseppe Mancia,Bertram Pitt,Arya M. Sharma,Peter Sleight,Koon K. Teo,Thomas Unger,Michael A. Weber,Bryan Williams,Faiez Zannad +16 more
TL;DR: The ultimate goal is to encourage the optimal management of individuals at high total cardiovascular risk according to evidence-based medicine, with the expectation that this will improve outcomes.
Journal ArticleDOI
Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database.
Giuseppe Mancia,Stefano Omboni,Irina Chazova,Antonio Coca,Xavier Girerd,Hermann Haller,Gianfranco Parati,Paolo Pauletto,Danuta Pupek-Musialik,Yevgeniya Svyshchenko +9 more
TL;DR: This large HBP database shows that the lercanidipine–enalapril combination lowers HBP more effectively than the corresponding monotherapies and placebo, and that this greater effect is consistent between days.
Journal ArticleDOI
Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial.
Giuseppe Mancia,Antonio Coca,Irina Chazova,Xavier Girerd,Hermann Haller,Paolo Pauletto,Danuta Pupek-Musialik,Yevgeniya Svyshchenko +7 more
TL;DR: In Stage 2 hypertension, a fixed-dose combination of L and E ensures a control of both office and out-of-office BP, with a favourable tolerability profile.